When tissue at a target site is illuminated with short pulses of light (with a pulse duration ranging from picoseconds to femtoseconds) emitted by a laser source, fluorophore molecules (either intrinsic or extrinsic) at the target site absorb photons of the light. The quantity of intrinsic fluorophore molecules such as NADH or FAD can indicate local metabolic activity, which can be used for detecting diseases. (NADH is Nicotinamide Adenine Dinucleotide (NAD) plus Hydrogen, i.e., the reduced form of NAD, while FAD is Flavin Adenine Dinucleotide.) Extrinsic fluorophore molecules (such as fluorescence labeled antibodies and ligands) are typically introduced into the tissue and can preferentially bind to specific cells or cell organelles of specific types of tissue, such as abnormal or cancerous tissue. The absorption of photons by the fluorophore molecules at the target site pumps electrons comprising the molecules from their normal ground state to higher excited energy levels. There is some radioactive decay, and then, when the electrons return to the ground energy state, they emit photons comprising a characteristic fluorescence light having a substantially lower energy, and therefore, longer wavelength than the exciting photon that was absorbed by the electron. Because the wavelengths of the exciting light pulses and the emitted fluorescence light from the fluorophore molecules are substantially different, they can readily be distinguished.
However, for most intrinsic fluorescence molecules to generate fluorescence, absorption of a single exciting photon from a laser pulse source requires the exciting light to be in the visible range. Unfortunately, visible light has a limited penetration depth in tissue. As an alternative to single photon excitation, the fluorescence molecules can be excited to produce fluorescence light as a result of the simultaneous absorption of two or more excitation photons of a longer wavelength (often with a deeper penetration depth in tissue, compared to shorter wavelengths), such as photons of near infrared light, that pump the electrons to the higher energy levels. The resultant emitted light is thus called multiphoton fluorescence (MPF) light. The lowest order multiphoton fluorescence process involves simultaneous absorption of two excitation photons. In this case, the process is called two-photon fluorescence (TPF). The efficiency of MPF is inversely proportional to the temporal pulse width of the excitation light. In general, the shorter the pulse width is, the higher will be the MPF efficiency.
Detection of the fluorescence light emitted from fluorophore molecules can thus be used for forming images of the target site showing the specific location of the tissue that includes the fluorophore molecules. Medical personnel can review the images to detect the presence and location of that specific tissue by thus imaging the MPF light.
A microscope is often used to image the fluorescence light emitted from fluorophore molecules in tissue of a target region. Further, for evaluating the condition of tissue at a target site within a patient's body, a fiber optic endoscope can be introduced into a patient's body and advanced to the site; the signal produced by the endoscope is then used for imaging the fluorescence light on a display. MPF imaging is now recognized as a powerful modality with unique characteristics that can provide high-resolution biochemical or molecular information complementary to the information provided by other biological imaging technologies.
The advantages of MPF imaging, particularly if not limited to ex vivo microscopy studies of tissue samples, include an intrinsic optical sectioning ability (due to a nonlinear multiphoton excitation process), deeper penetration depth into tissue (for example, as a result of using near infrared excitation light), and reduced photo-bleaching and photo-toxicity in the out-of-focus regions (due to the confinement of fluorescence excitation to the focal region). Recently, extensive research efforts have focused on developing miniature probes for MPF endoscopic imaging. Major challenges for such devices are beam scanning, efficient excitation light delivery, MPF signal collection, and probe miniaturization.
A nonlinear process similar to TPF can also occur in materials with a non-centrosymmetric molecular organization (such as a muscle fiber bundle, cartilage, or a well-organized collagen network in other types of tissue). In this case, two excitation photons are absorbed and excite the electron of the non-centrosymmetric molecule to a virtual higher energy state. Then, the excited electron relaxes to its ground state, resulting in a photon emission. The emitted photon has an energy that is equal to the sum of the energy of the two excitation photons (or twice as much as a single excitation photon). This process is called second harmonic generation (SHG). The non-centrosymmetric molecule that produces SHG photons or light is referred to herein as an “SHG molecule.” The SHG signal produced by detecting SHG light emitted from SHG molecules can reveal the integrity of the local tissue organization, which in turn, can be used for disease detection (such as the detection of cancerous tissue). Thus, the evaluation of tissue at a site based upon SHG light as well as upon the MPF emitted from the site when excited by incident excitation light can provide more complete information applicable to diagnostic functions.
This following discussion is directed to a scanning optical fiber endoscope for real-time imaging, e.g., for producing MPF and SHG images, as well as collecting spectroscopic information, which addresses the challenges mentioned above. Two-dimensional beam scanning is realized by resonantly scanning a fiber-optic cantilever with a tubular piezoelectric actuator. A double-clad optical fiber is used for delivery of excitation light and collection of emitted light from the internal target region. Detection electronics and the majority of the optical components including a dispersion compensator and dichroic mirror are placed at the input (or proximal) end of the flexible endoscope. The relatively few components required at the distal end include a small piezoelectric actuator configured to drive a cantilevered optical fiber to scan the target region, and a focusing lens, simplifying the alignment of these components and making the endoscope flexible and very compact.
More specifically, a system is described for capturing nonlinear optical images of a target region within a patient's body and providing other output information, including spectroscopic images. An exemplary embodiment of the system includes a light source that produces a pulsed light. An optical fiber having a core covered by a plurality of claddings extends between a proximal end and a distal end. The core is configured to couple at the proximal end of the optical fiber to the light source that is producing the pulsed light and conveys the pulsed light to the distal end of the optical fiber. A cantilevered optical fiber that includes a core within a plurality of claddings is coupled to the distal end of the optical fiber to receive the pulsed light, so that the pulsed light is conveyed through the core of the cantilevered optical fiber and exits from a free end of the cantilevered optical fiber. An actuator is included for driving the cantilevered optical fiber to move relative to one or more axes, so that the pulsed light exiting from the free end scans in a desired scanning pattern. The pulsed light exiting from the free end of the cantilevered optical fiber is focused by a lens toward a target region within a patient's body. The pulsed light excites molecules at the target region to emit light in response to the pulsed light, and the lens also focuses emitted light received from the target region back into the core and into an inner cladding of the cantilevered optical fiber. This emitted light is conveyed through the cantilevered optical fiber and through the core and an inner cladding of the optical fiber that is coupled thereto toward the proximal end of the optical fiber. At the proximal end of the optical fiber, a splitter is provided to separate the emitted light conveyed through the optical fiber along a detection path, from the pulsed light produced by the light source that is conveyed into the core of the optical fiber. An optical filter disposed in the detection path passes the emitted light, but rejects light having other wavelengths, such as the pulsed light and any background light that may be traveling along the detection path.
In one exemplary embodiment, a photodetector disposed in the detection path responds to the fluorescence light and produces a corresponding electrical output signal, while in another embodiment, the photodetector comprises a spectrometer and imaging device that produces an output signal indicative of spectroscopic information. The electrical output signal is processed by a processor for use determining characteristics of the internal region, e.g., for creating an image of the target region based upon the fluorescence light, or producing a spectrogram indicative of the intensity of different wavelengths in the MPF emission from the internal region.
Yet another exemplary embodiment includes a photodetector that is responsive to SHG, producing an output signal that is processed to produce SHG images of the internal region.
The splitter can include a dichroic mirror that transmits light of a first waveband (or range of wavelengths), while reflecting light of a second waveband that is substantially different than the first waveband. In this case, the pulsed light has a waveband that is substantially equal to one of the first and the second wavebands, while the emitted light has a waveband that is substantially equal to the other of the first and second waveband. Thus, the dichroic mirror can either transmit the pulsed light and reflect the emitted light, or transmit the emitted light and reflect the pulsed light.
In one exemplary embodiment, the actuator drives the cantilevered optical fiber to move in the desired scanning pattern defined relative to two generally orthogonal axes. The actuator is energized by a drive signal modulated with a voltage waveform selected from either a triangular waveform or a sinusoidal waveform (or modified versions of these basic drive waveforms). While other types of actuators can be employed, in this exemplary embodiment, the actuator comprises a tubular piezoelectric actuator.
Also included in the exemplary embodiment is a pulse dispersion manager that is disposed in a path between the light source of the pulsed light and proximal end of the optical fiber. The pulse dispersion manager negatively pre-chirps pulses of the pulsed light to compensate for a pulse broadening that is caused by a positive dispersion of the pulsed light within the core of the optical fiber. One exemplary embodiment of the pulse dispersion manager comprises a pulse stretcher that includes a grating, a lens, a folding mirror, and a reflective surface. In another exemplary embodiment, a photonic bandgap fiber (PBF) is employed as the pulse dispersion manager. In this exemplary embodiment of the pulse dispersion manager, a coupling lens is used at the input end (to couple short pulses into the PBF) and at the output end (to facilitate the coupling of short pulses into the double-clad optical fiber). The introduction of a PBF for pulse prechirping significantly reduces the overall system size and substantially reduces the excitation power loss that generally occurs in a pulse stretcher that has the grating and lens, thus allowing the use of a more compact and lower-cost short pulse laser source.
A lens can be included for coupling the pulsed light into the core at the proximal end of the optical fiber. The lens that focuses pulsed light exiting from the free end of the cantilevered optical fiber can comprise a micro lens such as a gradient index (GRIN) lens, or an achromatic micro-compound lens.
The light source that produces the pulsed light in this exemplary embodiment comprises a laser that produces pulses with a width on the order of about several femtoseconds to several tens of picoseconds.
Another aspect of this technology is directed to a method for producing light emission from a target region in a patient's body. The method includes the steps of introducing pulsed light into a proximal end of an optical fiber having a core and a plurality of cladding layers, so that the pulsed light is conveyed by the core to a distal end of the optical fiber. The distal end of the optical fiber is configured to be advanced to a position proximate to the target region. A scanning device disposed at the distal end of the optical fiber where the scanning device receives the pulsed light is activated to move so that the pulsed light scans the target region in a desired scanning pattern. The pulsed light from the scanning device is focused onto the target region causing molecules at the target region to emit light. Emitted light received from the target region is focused into the scanning device and is conveyed through the core and an inner cladding layer of the optical fiber, to the proximal end of the optical fiber. The emitted light exiting the optical fiber is directed so that the emitted light is incident on a photodetector. This photodetector produces a signal indicative of an intensity of the emitted light as the target region is scanned in the desired scanning pattern. The signal is processed to determine a characteristic of the target region, e.g., to produce an MPF image of the target region, or to produce an SHG image of the target region, or to produce a spectroscopic image of the target region that is wavelength dependent on the emitted light. Thus, the steps of the method are generally consistent with the functions of the system discussed above.
This Summary has been provided to introduce a few concepts in a simplified form that are further described in detail below in the Description. However, this Summary is not intended to identify key or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
Various aspects and attendant advantages of one or more exemplary embodiments and modifications thereto will become more readily appreciated as the same becomes better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein:
Figures and Disclosed Embodiments Are Not Limiting
Exemplary embodiments are illustrated in referenced Figures of the drawings. It is intended that the embodiments and Figures disclosed herein are to be considered illustrative rather than restrictive. No limitation on the scope of the technology and of the claims that follow is to be imputed to the examples shown in the drawings and discussed herein.
Optical Fiber Scanning Device
The scanning mechanism for the exemplary endoscope discussed below is an adaptation of a design initially developed for real-time optical coherence tomography. The endoscope in this exemplary embodiment includes a compact scanning device (shown in
By modulating the drive voltage with appropriate triangular or sinusoidal waveforms, a spiral scanning pattern is achieved in this exemplary embodiment. For example, for a probe with a free-standing cantilevered optical fiber length of ˜8.2 mm (with a diameter of about 125 μm), the scanning frequency ranges from about 1,323 to about 1,330 Hz for reasonable maximum scanning diameters of approximately 120-220 μm, using a maximum peak-to-peak drive voltage of about 75 volts. The overall diameter of the scanning endoscope is about 2.4 mm in this exemplary embodiment. However, it should be understood that none of the dimensions presented in this disclosure are intended to be in any way limiting on the scope of the concept. For example, endoscopes with longer or shorter cantilevered optical fibers can be employed, as well as endoscopes that have different diameters than this exemplary embodiment.
Modulating the sinusoidal drive waveform with a triangular envelope results in a spiral scanning pattern where the radius varies linearly in time. Unfortunately, discontinuity in the derivative of the modulation amplitude causes the probe to ring, distorting the image. Replacing the triangular modulation with smooth sinusoidal modulation envelopes 30 and 32 used to drive the piezoelectric actuators relative to the two orthogonal axes (see
Double-Clad Optical Fiber
For light delivery to a sample or target region, and emitted light collection arising from excitation of molecules at the sample or target region, a commercially available double-clad optical fiber 12 (for example, available from Fibercore Ltd.) was used. Double-clad optical fibers are characterized by having a central single-mode core 40 surrounded by an inner cladding 42, and an outer cladding 44, as shown in the example of
Exemplary System
An exemplary embodiment of a scanning optical fiber endoscope system 50 for nonlinear optical imaging and spectroscopy is shown in
One exemplary embodiment of pulse dispersion manager 57, which is illustrated in
A simpler exemplary embodiment for pulse dispersion management unit 57 is shown in
Referring again to
Thus, MPF comprises a fluorescence signal that is from the target region and is collected by micro-lens 70 (e.g., a GRIN lens with NA=0.46, a magnification of ˜0.7, and a working distance of ˜0.9 mm in this exemplary embodiment, although such details should not be considered to be in any way limiting). The fluorescence signal is conveyed through the core and inner cladding of cantilevered optical fiber 24 and double-clad optical fiber 66. (Note that the cantilevered optical fiber can comprise the distal end of the double-clad optical fiber or can be mechanically coupled to the distal end of the double-clad optical fiber, e.g., so that the core, inner cladding, and outer cladding portions of the double-clad optical fiber are thermally fused or mechanically or adhesively bonded to the corresponding component portions of the cantilevered optical fiber.) The fluorescence signal exiting the proximal end of double-clad optical fiber 66 is directed towards a photodetector (PD) 74 using DM 62, and residual excitation light is further blocked by an optical filter (OF) 73, which can comprise both a short-pass filter (e.g., with a cut-off wavelength of 650 nm) and a bandpass filter (e.g., passing light with wavelengths in the range from 350 nm-650 nm), which is disposed in front of the PD.
Finally, the signal from PD 74 is amplified by an amplifier 76, and digitized and conditioned by a data acquisition system (DAQ) 78. The conditioned digital signal is supplied to a computer 80 (or other computing device or processor) for processing and can either be stored and/or displayed on a display monitor 82, which enables MPF, and/or SHG, and/or spectroscopic images to be viewed and further analyzed by medical personnel. Theses images can be used for various purposes, such as to determine whether cancerous cells are present at the sample or target region.
Photodetector (PD)
As indicated in an exemplary embodiment of PD 74 illustrated in
For MPF spectroscopy, PD 74 can comprises a spectrometer 75, followed by a charge coupled device (CCD) array 77. Thus, imaging can be performed spectroscopically to produce MPF images at any desired specific wavelength within the MPF spectrum range. The scanning endoscope can also perform MPF spectroscopy imaging. For this type of application, spectrometer 75 is an imaging spectrometer, and CCD array 77 is used to read out spectroscopic information (i.e., the intensity at different wavelengths of the MPF emission spectrum). The spectroscopy (or wavelength dependent) information can facilitate the differentiation of abnormal tissue from normal tissue, which provides another avenue of disease detection in addition to the overall MPF intensity images.
The image of 2.2-μm fluorescence beads 92, which is shown in
In the exemplary system discussed above, only the linear dispersion of the double-clad optical fiber is compensated. Previous studies have shown that even at moderate pulse energies, self-phase modulation can significantly modify pulse widths and affect the generation of multiphoton fluorescence. In this exemplary system, the typical average power in the core of the fiber is 10 mW. Previous research has shown that in this range of power levels, nonlinear pulse propagation can begin to modify the pulse shape and spectrum, which in turn, can reduce the multi-photon excitation efficiency. The use of special optical fibers with low dispersion values or the implementation of appropriate schemes to reduce the nonlinear dispersion effects is expected to improve the signal levels.
Thus, an exemplary optical fiber endoscope for scanning MPF, SHG, in real-time imaging, and collecting spectroscopic information has been developed, as discussed above. A piezoelectric actuator for optical fiber tip scanning enables real-time imaging in vivo, and a double-clad optical fiber that is used for both excitation light delivery and collection of the MPF light addresses some of the key challenges associated with the use of a conventional single mode optical fiber (i.e., endoscopic beam scanning and low collection efficiency). By using the same optical fiber for both delivery of the excitation pulsed light and collection of emitted light from molecules at the site, a flexible and compact endoscope has been constructed, which can be potentially integrated with existing endoscopic technology for real-time, in vivo imaging of internal organs, and for other applications, as will be evident to one of ordinary skill in the art.
Although the concepts disclosed herein have been described in connection with the preferred form of practicing them and modifications thereto, those of ordinary skill in the art will understand that many other modifications can be made thereto within the scope of the claims that follow. Accordingly, it is not intended that the scope of these concepts in any way be limited by the above description, but instead be determined entirely by reference to the claims that follow.
This application is based on a prior copending provisional application, Ser. No. 60/759,405, filed on Jan. 17, 2006, the benefit of the filing date of which is hereby claimed under 35 U.S.C. § 119(e).
This invention was funded at least in part with a grant (No. BES-0348720) from the National Science Foundation, a grant (No. 5R21EB0032840-02) from the National Institutes of Health, and the U.S. government may have certain rights in this invention.
Number | Date | Country | |
---|---|---|---|
60759405 | Jan 2006 | US |